Form 4: Phillip Frost's Trust Acquires 500,000 Shares of OPKO Health

Phillip Frost's Frost Gamma Investments Trust purchased 500,000 shares of OPKO Health at an average price of $1.5621 per share.

Summary

• Phillip Frost's Frost Gamma Investments Trust acquired 500,000 shares of OPKO Health common stock.
• The shares were purchased on December 11, 2024.
• The price per share ranged from $1.535 to $1.61, with a weighted average price of $1.5621.
• The total number of shares held by Frost Gamma Investments Trust is 3,568,951.
• Phillip Frost, M.D., is the trustee of Frost Gamma Investments Trust and also has indirect control through other entities.
• Phillip Frost disclaims beneficial ownership of these securities except to the extent of any pecuniary interest.

Sentiment

Score: 7

Explanation: The insider purchase is a positive sign, but the disclaimer of beneficial ownership and the price range introduce some complexity. Overall, it's a moderately positive event.

Positives

• The purchase of 500,000 shares by a major shareholder like Phillip Frost could be seen as a positive signal for the company's prospects.
• The purchase demonstrates confidence in OPKO Health by a key insider.

Risks

• The document includes a disclaimer of beneficial ownership by Phillip Frost, except for pecuniary interest, which could indicate a complex ownership structure.
• The purchase price range indicates some price volatility during the transaction.

Management Comments

• Phillip Frost disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest.

Industry Context

Insider trading activity is closely monitored by regulators and investors as it can provide insights into the company's prospects. This purchase by a major shareholder like Phillip Frost is a notable event.

Comparison to Industry Standards

• Insider purchases are common, but the size of this transaction (500,000 shares) is significant.
• Comparable transactions would include other large insider purchases in the healthcare sector, such as those by executives at companies like Regeneron or Amgen, which are often seen as positive signals.

Stakeholder Impact

• The share purchase could positively impact shareholder confidence.
• The purchase may have a neutral impact on employees, customers, suppliers, and creditors.

Key Dates

Keywords

OPKO Health, Phillip Frost, Frost Gamma Investments Trust, share purchase, insider trading, common stock, beneficial ownership